Tuesday, April 23, 2024 8:00 – 8:15 AM
Location: Asbury Hall A-B, Disney Yacht Club

Session Description:

UF College of Medicine Dean Hunt and Dr. Brusko welcome conference-goers to day two.

About the Speaker:


University of Florida

Jennifer Hunt, MD, MEd

Jennifer L. Hunt, M.D., M.Ed., has served as interim dean of the University of Florida College of Medicine since Jan. 2. Hunt, who serves as chair of the college’s department of pathology, immunology and laboratory medicine and UF Health Shands chief of staff, brings a wealth of administrative experience to the role. At UF Health, she has directed credentialed medical staff and served as the chief medical administrative officer, advising on clinical policies and best practices. She has also been responsible for the application and enforcement of the bylaws, policies, rules and regulations of the hospital and its medical staff, and for the oversight of the Medical Executive Committee and the Credentials Committee.

As interim dean, Hunt will oversee the continued growth in the college’s academic missions, implementation of the new faculty compensation plan, expansion and clinical integration of the quality and patient safety initiative, clinical service line development, programs for faculty and staff retention, strategic expansion of the research enterprise and innovation in educational programs.


University of Florida

Todd Brusko, PhD

Dr. Todd Brusko is appointed as a Professor in the Department of Pathology at the University of Florida College of Medicine. He currently serves as the Research Director of the UF Diabetes Institute. The research interests of the Brusko Laboratory are centrally themed around understanding the mechanisms by which the immune system maintains a state of control, often referred to as immunological tolerance. This includes studies of the innate and adaptive immune system, with a particular focus on the TCR repertoire and costimulation of T cells and regulatory T cells. A portion of the Brusko lab is dedicated to understanding the genetic variants controlling these processes, as well as identifying the mechanisms at play in individuals who develop immune-mediated diseases. As evidence of this, Dr. Brusko has previously published over 100 studies reporting cellular immune defects in patients with type 1 diabetes (T1D), lupus, sepsis, and cancer and investigated cellular immune mechanisms and biological basis of such diseases.